These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 26285873)

  • 21. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
    Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
    Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
    Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
    J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kynurenine Pathway Metabolites in Alzheimer's Disease.
    Giil LM; Midttun Ø; Refsum H; Ulvik A; Advani R; Smith AD; Ueland PM
    J Alzheimers Dis; 2017; 60(2):495-504. PubMed ID: 28869479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
    Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
    Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
    Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
    Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
    Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
    Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.
    Clarke G; Fitzgerald P; Cryan JF; Cassidy EM; Quigley EM; Dinan TG
    BMC Gastroenterol; 2009 Jan; 9():6. PubMed ID: 19154614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
    Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
    Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.
    Lee SA; Mefford JA; Huang Y; Witte JS; Martin JN; Haas DW; Mclaren PJ; Mushiroda T; Kubo M; Byakwaga H; Hunt PW; Kroetz DL
    AIDS; 2016 Jul; 30(11):1807-15. PubMed ID: 27088321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
    Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
    Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the tryptophan/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study.
    Meier MA; Ottiger M; Vögeli A; Steuer C; Bernasconi L; Thomann R; Christ-Crain M; Henzen C; Hoess C; Zimmerli W; Huber A; Mueller B; Schuetz P
    Clin Chem Lab Med; 2017 Jun; 55(7):1060-1069. PubMed ID: 28076309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa.
    Byakwaga H; Hunt PW; Laker-Oketta M; Glidden DV; Huang Y; Bwana BM; Mocello AR; Bennett J; Walusansa V; Dollard SC; Bangsberg DR; Mbidde EK; Martin JN
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):296-303. PubMed ID: 26181812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
    Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
    Front Immunol; 2020; 11():31. PubMed ID: 32153556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
    Heyes MP; Chen CY; Major EO; Saito K
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
    Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
    Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.